| Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis HH Dasenbrock, KX Liu, CA Devine, V Chavakula, TR Smith, WB Gormley, ... Neurosurgical focus 39 (6), E12, 2015 | 144 | 2015 |
| Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma S Derks, KS Nason, X Liao, MD Stachler, KX Liu, JB Liu, E Sicinska, ... Cancer immunology research 3 (10), 1123-1129, 2015 | 137 | 2015 |
| Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas S Derks, LK de Klerk, X Xu, T Fleitas, KX Liu, Y Liu, F Dietlein, C Margolis, ... Annals of Oncology 31 (8), 1011-1020, 2020 | 112 | 2020 |
| Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis KX Liu, B Edwards, S Lee, MJ Finelli, B Davies, KE Davies, PL Oliver Brain 138 (5), 1167-1181, 2015 | 85 | 2015 |
| A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents L Xu, KX Liu, MM Senna Frontiers in Medicine 4, 112, 2017 | 81 | 2017 |
| Ctip1 regulates the balance between specification of distinct projection neuron subtypes in deep cortical layers MB Woodworth, LC Greig, KX Liu, GC Ippolito, HO Tucker, JD Macklis Cell Reports 15 (5), 999-1012, 2016 | 77 | 2016 |
| Dual HDAC and PI3K inhibition abrogates NFκB-and FOXM1-mediated DNA damage response to radiosensitize pediatric high-grade gliomas S Pal, D Kozono, X Yang, W Fendler, W Fitts, J Ni, JA Alberta, J Zhao, ... Cancer research 78 (14), 4007-4021, 2018 | 72 | 2018 |
| The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress MJ Finelli, L Sanchez-Pulido, KX Liu, KE Davies, PL Oliver Journal of Biological Chemistry 291 (6), 2751-2763, 2016 | 71 | 2016 |
| Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations MJ Finelli, KX Liu, Y Wu, PL Oliver, KE Davies Human molecular genetics 24 (12), 3529-3544, 2015 | 69 | 2015 |
| A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia N Smedemark-Margulies, CA Brownstein, S Vargas, SK Tembulkar, ... Molecular Case Studies 2 (5), a001008, 2016 | 59 | 2016 |
| “Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma KX Liu, S Joshi Frontiers in Immunology 11, 1947, 2020 | 45 | 2020 |
| Prospective evaluation of radiation dose escalation in patients with high-risk neuroblastoma and gross residual disease after surgery: a report from the Children's Oncology … KX Liu, A Naranjo, FF Zhang, SG DuBois, SE Braunstein, SD Voss, ... Journal of clinical oncology: official journal of the American Society of …, 2020 | 43 | 2020 |
| A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma S Pal, JP Kaplan, H Nguyen, SA Stopka, MR Savani, MS Regan, ... Cancer Cell 40 (9), 957-972. e10, 2022 | 41 | 2022 |
| SF2523: Dual PI3K/BRD4 inhibitor blocks tumor immunosuppression and promotes adaptive immune responses in cancer S Joshi, AR Singh, KX Liu, TV Pham, M Zulcic, D Skola, HB Chun, ... Molecular cancer therapeutics 18 (6), 1036-1044, 2019 | 40 | 2019 |
| Body habitus, serum albumin, and the outcomes after craniotomy for tumor: a National Surgical Quality Improvement Program analysis HH Dasenbrock, KX Liu, V Chavakula, CA Devine, WB Gormley, ... Journal of neurosurgery 126 (3), 677-689, 2017 | 37 | 2017 |
| A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma KX Liu, M Ioakeim-Ioannidou, MS Susko, AD Rao, BY Yeap, AM Snijders, ... International Journal of Radiation Oncology* Biology* Physics 109 (3), 726-735, 2021 | 36 | 2021 |
| Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era N Manoharan, KX Liu, S Mueller, DA Haas-Kogan, P Bandopadhayay Neoplasia 36, 100857, 2023 | 35 | 2023 |
| Clinical Characteristics, Experiences, and Outcomes of Transgender Patients With Cancer ZT Burns, DS Bitterman, S Perni, PJ Boyle, CE Guss, DA Haas-Kogan, ... JAMA oncology, 2020 | 33 | 2020 |
| Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression S Joshi, KX Liu, M Zulcic, AR Singh, D Skola, CK Glass, PD Sanders, ... Molecular cancer therapeutics 19 (3), 755-764, 2020 | 31 | 2020 |
| Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis HH Dasenbrock, CA Devine, KX Liu, WB Gormley, EB Claus, TR Smith, ... Cancer 122 (11), 1708-1717, 2016 | 29 | 2016 |
Christopher A. DevineMD/MBA Candidate, Harvard Medical School & Harvard Business School在 hms.harvard.edu 的电子邮件经过验证
